Genetic and Pharmacological Inhibition of GCN2 Ameliorates Hyperglycemia and Insulin Resistance in Type 2 Diabetic Mice
It is well recognized that there is a strong and complex association between nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes (T2D). We previously demonstrated that genetic knockout or pharmacological inhibition of general control nondepressible kinase 2 (GCN2), a well-known amino acid s...
Saved in:
Main Authors: | Juntao Yuan (Author), Fang Li (Author), Xiyue Shen (Author), Junling Gao (Author), Zhuoran Yu (Author), Kai Luo (Author), Bingqing Cui (Author), Zhongbing Lu (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Inhibition of GCN2 Alleviates Cardiomyopathy in Type 2 Diabetic Mice via Attenuating Lipotoxicity and Oxidative Stress
by: Juntao Yuan, et al.
Published: (2022) -
Hepatic DDAH1 mitigates hepatic steatosis and insulin resistance in obese mice: Involvement of reduced S100A11 expression
by: Xiyue Shen, et al.
Published: (2023) -
DDAH1 Protects against Acetaminophen-Induced Liver Hepatoxicity in Mice
by: Xiyue Shen, et al.
Published: (2022) -
IDO1 Inhibitor RY103 Suppresses Trp-GCN2-Mediated Angiogenesis and Counters Immunosuppression in Glioblastoma
by: Zikang Xing, et al.
Published: (2024) -
Trial of Insulin for Poststroke Hyperglycemia
by: J Gordon Millichap
Published: (2010)